Over 400 firms, including Cipla, Airtel & Tata Steel, to unveil Q4 results this week. Track key announcements and dividend…
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…
Pharma stocks fall as Nifty Pharma drops 3%. Sun Pharma, Cipla slide amid US tariff fears and export risk concerns.
Novo Nordisk’s next-gen obesity drug CagriSema failed to match Eli Lilly’s Zepbound in a head-to-head trial, sending shares down 16%…
More than 12 years after the Obama admin debuted the Healthcare.gov platform, Trump has announced the launch of his TrumpRx…
Super investor and a Warren Buffett of India, Mukul Agarwal, has just added two new stocks to his portfolio sending…
Pfizer has launched Rimegepant ODT in India for adults who don’t respond to triptans. The fast-acting tablet offers up to…
The deals set a framework the White House will use to try to reach its goal of lowering U.S. prescription…
In recent years, several multinational companies have exited Pakistan, by either selling stakes or operations, even though it is the…
Trump said he expects other drugmakers to follow suit. Here are details of the agreement:
Stocks of Pfizer, Moderna, and BioNTech plummet after reports of child deaths linked to COVID-19 vaccines. Trump administration is also…
California sees a rise in COVID-19 cases as the new LP.8.1 variant spreads. Learn about the latest vaccine updates, eligibility,…
Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 dangerous bacterial strains, helping…
A Turkish study finds Pfizer’s COVID-19 vaccine may cause temporary changes in corneal thickness and cell count, raising concerns for…
Pfizer has abandoned the development of the experimental oral weight-loss drug danuglipron.
Bourla’s comments come as drugmakers brace for the possibility of 25% tariff on pharmaceutical imports.
Recently, Pfizer has launched a specialised centre at a hospital in Gurugram and is planning to start more such centres…
Pfizer is testing both a once-daily modified release dosing and also a twice-daily form of danuglipron